PM2.5成分对肺功能恶化的影响以及慢性肺病患者系统性炎症的修饰作用
Jiayu Xu1, Zekang Su2, Yuxuan Nie3
1School of Public Health, Peking University, Beijing 100191, China.
Ecotoxicology and environmental safety
|October 14, 2025
概括
细颗粒物 (PM2.5) 和其组成部分如黑碳 (BC) 和硫酸盐 (SO42−) 在患有慢性肺病的患者中显著恶化肺功能. 较高的C-反应蛋白 (CRP) 水平加剧了这些有害影响,突出了排放控制和抗炎策略的必要性.
科学领域:
- 环境健康 环境健康
- 肺部医学 肺部医学
- 毒理学 毒理学 毒理学
背景情况:
- 颗粒物 (PM2.5) 暴露会对肺功能产生负面影响,但其特定的有毒成分和与全身炎症的相互作用尚未完全理解.
- 以前的研究表明,PM2.5会损害肺功能,但其成分的独特作用和与炎症的协同作用需要进一步研究.
研究的目的:
- 研究长期暴露于PM2.5及其成分与中国成年人的肺功能下降之间的关联.
- 确定导致肺功能受损的关键有毒PM2.5成分.
- 检查系统性炎症对这些关联的修饰作用,由C-反应蛋白 (CRP) 表示.
主要方法:
- 中国的一项全国性横截面研究,涉及1182名45-89岁的慢性肺病成年人.
- 使用权重定量总和 (WQS) 回归来评估PM2.5成分 (SO42−,NO3−,NH4+,BC,OM) 对峰值呼气流 (PEF) 的综合影响.
- 进行了相互作用分析,以评估C-反应蛋白 (CRP) 在修改PM2.5-肺功能关系中的作用.
主要成果:
- 增加暴露于PM2.5及其成分 (SO42−,NO3−,NH4+,BC,OM) 与减少PEF显著相关.
- 黑碳 (BC) 和硫酸盐 (SO42−) 被确定为影响最大的成分,其WQS重量分别为0.780和0.206.
- 升高的CRP水平与PEF进一步下降有关,这表明炎症加剧了PM2.5成分对肺功能的不良影响.
结论:
- 长期暴露于PM2.5,特别是其成分BC和SO42−,在患有慢性肺病的个体中显著损害肺功能.
- 较高的C-反应蛋白水平会放大PM2.5成分对肺功能的负面影响.
- 针对性地减少特定的PM2.5排放和实施抗炎干预措施对于保护高风险人群至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K


